Cargando…
Targeting the premetastatic niche: epigenetic therapies in the spotlight
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211564/ https://www.ncbi.nlm.nih.gov/pubmed/32390001 http://dx.doi.org/10.1038/s41392-020-0165-3 |
_version_ | 1783531465440493568 |
---|---|
author | Low, Vivien Blenis, John Gomes, Ana P. |
author_facet | Low, Vivien Blenis, John Gomes, Ana P. |
author_sort | Low, Vivien |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7211564 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-72115642020-05-14 Targeting the premetastatic niche: epigenetic therapies in the spotlight Low, Vivien Blenis, John Gomes, Ana P. Signal Transduct Target Ther Research Highlight Nature Publishing Group UK 2020-05-11 /pmc/articles/PMC7211564/ /pubmed/32390001 http://dx.doi.org/10.1038/s41392-020-0165-3 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Highlight Low, Vivien Blenis, John Gomes, Ana P. Targeting the premetastatic niche: epigenetic therapies in the spotlight |
title | Targeting the premetastatic niche: epigenetic therapies in the spotlight |
title_full | Targeting the premetastatic niche: epigenetic therapies in the spotlight |
title_fullStr | Targeting the premetastatic niche: epigenetic therapies in the spotlight |
title_full_unstemmed | Targeting the premetastatic niche: epigenetic therapies in the spotlight |
title_short | Targeting the premetastatic niche: epigenetic therapies in the spotlight |
title_sort | targeting the premetastatic niche: epigenetic therapies in the spotlight |
topic | Research Highlight |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211564/ https://www.ncbi.nlm.nih.gov/pubmed/32390001 http://dx.doi.org/10.1038/s41392-020-0165-3 |
work_keys_str_mv | AT lowvivien targetingthepremetastaticnicheepigenetictherapiesinthespotlight AT blenisjohn targetingthepremetastaticnicheepigenetictherapiesinthespotlight AT gomesanap targetingthepremetastaticnicheepigenetictherapiesinthespotlight |